These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 220051)
21. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma. Ammatuna P; de Thè G; Speciale R; Sammartano F; Arista S; Zerillo G Microbiologica; 1988 Apr; 11(2):89-94. PubMed ID: 2841559 [TBL] [Abstract][Full Text] [Related]
22. Nasopharyngeal carcinoma in Israel: epidemiology and Epstein-Barr virus-related serology. Bogger-Goren S; Gotlieb-Stematsky T; Rachima M; Barkowsky E; Schlomo-David J Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1277-81. PubMed ID: 2824207 [TBL] [Abstract][Full Text] [Related]
23. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients]. Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138 [TBL] [Abstract][Full Text] [Related]
24. [IgG- and IgA-antibodies to the Epstein-Barr virus in the sera of patients with nasopharyngeal carcinoma in Cuba]. Gurtsevich VE; Ruíz García R; Cuevas J; Le Riverand Morales E; Ascue M Vopr Virusol; 1979; (4):392-9. PubMed ID: 225887 [TBL] [Abstract][Full Text] [Related]
25. [Significance of virus-specific antibodies to EBV-antigens in patients with nasopharyngeal carcinoma (author's transl)]. Wilmes E; Wolf H; Deinhardt F; Naumann HH Laryngol Rhinol Otol (Stuttg); 1979 Dec; 58(12):911-5. PubMed ID: 231716 [TBL] [Abstract][Full Text] [Related]
26. Nasopharyngeal carcinoma due to Epstein-Barr virus: serologic tests. Smith TF Mayo Clin Proc; 1985 Mar; 60(3):205-6. PubMed ID: 2983152 [No Abstract] [Full Text] [Related]
27. IgA and nasopharyngeal carcinoma. Desgranges C; De-The G IARC Sci Publ (1971); 1978; (24 Pt 2):883-91. PubMed ID: 221410 [No Abstract] [Full Text] [Related]
28. Epstein-Barr virus-related antibody. Changes in titers after therapy for nasopharyngeal carcinoma. Neel HB; Taylor WF Arch Otolaryngol Head Neck Surg; 1990 Nov; 116(11):1287-90. PubMed ID: 2173618 [TBL] [Abstract][Full Text] [Related]
29. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma]. Amador García JM; Mendoza Montero J; Expósito Hernández J; Salinero Hernández J; Esquivias López-Cuerpo J; Ballesteros García P Acta Otorrinolaringol Esp; 1992; 43(1):31-6. PubMed ID: 1316136 [TBL] [Abstract][Full Text] [Related]
30. [IgG and IgA antibodies to the Epstein-Barr virus and nasopharyngeal carcinoma]. Vera Sempere FJ Med Clin (Barc); 1992 May; 98(19):758-9. PubMed ID: 1318986 [No Abstract] [Full Text] [Related]
31. Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy. Sham JS; Wei WI; Zong YS; Choy D; Guo YQ; Luo Y; Lin ZX; Ng MH Lancet; 1990 Feb; 335(8686):371-4. PubMed ID: 1968116 [TBL] [Abstract][Full Text] [Related]
32. The genetic and antigenic basis for the IgA antibody response to Epstein-Barr viral capsid antigen. Ng MH; Ho HC; Kwan HC IARC Sci Publ (1971); 1978; (20):449-58. PubMed ID: 215527 [No Abstract] [Full Text] [Related]
33. Long-term follow-up of IgG and IgA antibodies against viral capsid antigens of Epstein-Barr virus in nasopharyngeal carcinoma. Lynn TC; Tu SM; Kawamura A J Laryngol Otol; 1985 Jun; 99(6):567-72. PubMed ID: 2989398 [TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr-specific IgA in nasopharyngeal cancer. Lancet; 1978 Jun; 1(8078):1345-6. PubMed ID: 78104 [No Abstract] [Full Text] [Related]
35. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins. Kurstak E; de Thé G; van den Hurk J; Charpentier G; Kurstak C; Tijssen P; Morisset R J Med Virol; 1978; 2(3):189-200. PubMed ID: 212523 [TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma. Ho HC; Ng MH; Kwan HC; Chau JC Br J Cancer; 1976 Dec; 34(6):655-60. PubMed ID: 188437 [TBL] [Abstract][Full Text] [Related]
37. [Humoral response to Epstein-Barr virus of patients with nasopharyngeal cancer and its use in the differential diagnosis of the disease]. Gurtsevich VE; Plakhov IV; Chuĭkina NA; Abdulin NA Vestn Akad Med Nauk SSSR; 1984; (5):29-34. PubMed ID: 6331022 [No Abstract] [Full Text] [Related]
38. Proper use of serum antibody titres against Epstein-Barr virus in nasopharyngeal carcinoma: IgA/virus capsid antigen for diagnosis and EBV-related nuclear antigen-2 for follow-up. Shimakage M; Dezawa T; Chatani M Acta Otolaryngol; 2000 Jan; 120(1):100-4. PubMed ID: 10779195 [TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr viral serology in nasopharyngeal carcinoma patients in the USSR and Cuba, and its value for differential diagnosis of the disease. Gurtsevitch V; Ruiz R; Stepina V; Plachov I; Le Riverend E; Glazkova T; Lavoué MF; Paches A; Aliev B; Mazurenko N Int J Cancer; 1986 Mar; 37(3):375-81. PubMed ID: 3005177 [TBL] [Abstract][Full Text] [Related]
40. Epstein--Barr virus-associated antibodies in IgG and IgA of nasopharyngeal carcinoma patients. Yang CS; Yang HM; Yeh YS; Lynn TC Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):167-75. PubMed ID: 228890 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]